UniProt ID | DDX24_HUMAN | |
---|---|---|
UniProt AC | Q9GZR7 | |
Protein Name | ATP-dependent RNA helicase DDX24 | |
Gene Name | DDX24 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 859 | |
Subcellular Localization | ||
Protein Description | ATP-dependent RNA helicase.. | |
Protein Sequence | MKLKDTKSRPKQSSCGKFQTKGIKVVGKWKEVKIDPNMFADGQMDDLVCFEELTDYQLVSPAKNPSSLFSKEAPKRKAQAVSEEEEEEEGKSSSPKKKIKLKKSKNVATEGTSTQKEFEVKDPELEAQGDDMVCDDPEAGEMTSENLVQTAPKKKKNKGKKGLEPSQSTAAKVPKKAKTWIPEVHDQKADVSAWKDLFVPRPVLRALSFLGFSAPTPIQALTLAPAIRDKLDILGAAETGSGKTLAFAIPMIHAVLQWQKRNAAPPPSNTEAPPGETRTEAGAETRSPGKAEAESDALPDDTVIESEALPSDIAAEARAKTGGTVSDQALLFGDDDAGEGPSSLIREKPVPKQNENEEENLDKEQTGNLKQELDDKSATCKAYPKRPLLGLVLTPTRELAVQVKQHIDAVARFTGIKTAILVGGMSTQKQQRMLNRRPEIVVATPGRLWELIKEKHYHLRNLRQLRCLVVDEADRMVEKGHFAELSQLLEMLNDSQYNPKRQTLVFSATLTLVHQAPARILHKKHTKKMDKTAKLDLLMQKIGMRGKPKVIDLTRNEATVETLTETKIHCETDEKDFYLYYFLMQYPGRSLVFANSISCIKRLSGLLKVLDIMPLTLHACMHQKQRLRNLEQFARLEDCVLLATDVAARGLDIPKVQHVIHYQVPRTSEIYVHRSGRTARATNEGLSLMLIGPEDVINFKKIYKTLKKDEDIPLFPVQTKYMDVVKERIRLARQIEKSEYRNFQACLHNSWIEQAAAALEIELEEDMYKGGKADQQEERRRQKQMKVLKKELRHLLSQPLFTESQKTKYPTQSGKPPLLVSAPSKSESALSCLSKQKKKKTKKPKEPQPEQPQPSTSAN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Ubiquitination | ----MKLKDTKSRPK ----CCCCCCCCCCC | 58.81 | 24816145 | |
6 | Phosphorylation | --MKLKDTKSRPKQS --CCCCCCCCCCCCC | 29.36 | - | |
17 | Acetylation | PKQSSCGKFQTKGIK CCCCCCCCCCCCCEE | 38.33 | 19608861 | |
17 | Ubiquitination | PKQSSCGKFQTKGIK CCCCCCCCCCCCCEE | 38.33 | 19608861 | |
21 | Acetylation | SCGKFQTKGIKVVGK CCCCCCCCCEEEEEE | 48.10 | 23749302 | |
21 | Ubiquitination | SCGKFQTKGIKVVGK CCCCCCCCCEEEEEE | 48.10 | 33845483 | |
24 | Acetylation | KFQTKGIKVVGKWKE CCCCCCEEEEEECEE | 39.27 | 25953088 | |
28 | Acetylation | KGIKVVGKWKEVKID CCEEEEEECEEEECC | 43.41 | 26051181 | |
54 | Phosphorylation | LVCFEELTDYQLVSP EEEHHHCCCCCCCCC | 35.62 | 28450419 | |
56 | Phosphorylation | CFEELTDYQLVSPAK EHHHCCCCCCCCCCC | 9.86 | 28450419 | |
60 | Phosphorylation | LTDYQLVSPAKNPSS CCCCCCCCCCCCHHH | 27.94 | 25159151 | |
66 | Phosphorylation | VSPAKNPSSLFSKEA CCCCCCHHHCCCCCC | 49.41 | 28450419 | |
67 | Phosphorylation | SPAKNPSSLFSKEAP CCCCCHHHCCCCCCC | 34.39 | 28450419 | |
70 | Phosphorylation | KNPSSLFSKEAPKRK CCHHHCCCCCCCHHH | 34.57 | 28450419 | |
71 | Acetylation | NPSSLFSKEAPKRKA CHHHCCCCCCCHHHC | 51.03 | 19608861 | |
71 | Ubiquitination | NPSSLFSKEAPKRKA CHHHCCCCCCCHHHC | 51.03 | 32015554 | |
82 | Phosphorylation | KRKAQAVSEEEEEEE HHHCCCCCHHHHHHC | 42.16 | 29255136 | |
92 | Phosphorylation | EEEEEGKSSSPKKKI HHHHCCCCCCCCHHH | 47.07 | 23401153 | |
93 | Phosphorylation | EEEEGKSSSPKKKIK HHHCCCCCCCCHHHE | 54.89 | 22167270 | |
94 | Phosphorylation | EEEGKSSSPKKKIKL HHCCCCCCCCHHHEE | 48.07 | 22167270 | |
104 | Phosphorylation | KKIKLKKSKNVATEG HHHEECCCCCCCCCC | 28.07 | 29083192 | |
109 | Phosphorylation | KKSKNVATEGTSTQK CCCCCCCCCCCCCCE | 30.57 | 29083192 | |
112 | Phosphorylation | KNVATEGTSTQKEFE CCCCCCCCCCCEEEE | 23.51 | 25159151 | |
113 | Phosphorylation | NVATEGTSTQKEFEV CCCCCCCCCCEEEEE | 39.43 | 25159151 | |
114 | Phosphorylation | VATEGTSTQKEFEVK CCCCCCCCCEEEEEC | 43.42 | 25159151 | |
143 | Phosphorylation | DPEAGEMTSENLVQT CCCCCCCCHHHHHHC | 28.69 | - | |
166 | Phosphorylation | GKKGLEPSQSTAAKV CCCCCCCCCCCCCCC | 27.64 | 17525332 | |
172 | Acetylation | PSQSTAAKVPKKAKT CCCCCCCCCCCCCCC | 57.51 | 25953088 | |
172 | Ubiquitination | PSQSTAAKVPKKAKT CCCCCCCCCCCCCCC | 57.51 | 29967540 | |
178 | Ubiquitination | AKVPKKAKTWIPEVH CCCCCCCCCCCCHHC | 53.95 | 29967540 | |
188 | Acetylation | IPEVHDQKADVSAWK CCHHCCCCCCHHHHH | 53.24 | 25953088 | |
188 | Ubiquitination | IPEVHDQKADVSAWK CCHHCCCCCCHHHHH | 53.24 | 29967540 | |
192 | Phosphorylation | HDQKADVSAWKDLFV CCCCCCHHHHHHHCC | 29.03 | 22817900 | |
195 | 2-Hydroxyisobutyrylation | KADVSAWKDLFVPRP CCCHHHHHHHCCCHH | 44.25 | - | |
195 | Acetylation | KADVSAWKDLFVPRP CCCHHHHHHHCCCHH | 44.25 | 26051181 | |
195 | Ubiquitination | KADVSAWKDLFVPRP CCCHHHHHHHCCCHH | 44.25 | 21890473 | |
208 | Phosphorylation | RPVLRALSFLGFSAP HHHHHHHHHHCCCCC | 19.90 | 24114839 | |
213 | Phosphorylation | ALSFLGFSAPTPIQA HHHHHCCCCCCHHHH | 31.38 | 24114839 | |
230 | 2-Hydroxyisobutyrylation | LAPAIRDKLDILGAA HHHHHHHHCEEECEE | 37.90 | - | |
230 | Acetylation | LAPAIRDKLDILGAA HHHHHHHHCEEECEE | 37.90 | 25953088 | |
230 | Ubiquitination | LAPAIRDKLDILGAA HHHHHHHHCEEECEE | 37.90 | 29967540 | |
268 | Phosphorylation | RNAAPPPSNTEAPPG HCCCCCCCCCCCCCC | 63.26 | 20068231 | |
270 | Phosphorylation | AAPPPSNTEAPPGET CCCCCCCCCCCCCCC | 37.55 | 21406692 | |
277 | Phosphorylation | TEAPPGETRTEAGAE CCCCCCCCCCCCCCC | 49.13 | 21406692 | |
279 | Phosphorylation | APPGETRTEAGAETR CCCCCCCCCCCCCCC | 37.29 | 23401153 | |
285 | Phosphorylation | RTEAGAETRSPGKAE CCCCCCCCCCCCCHH | 35.59 | 25159151 | |
287 | Phosphorylation | EAGAETRSPGKAEAE CCCCCCCCCCCHHHH | 45.48 | 29255136 | |
290 | Ubiquitination | AETRSPGKAEAESDA CCCCCCCCHHHHCCC | 46.57 | 22817900 | |
295 | Phosphorylation | PGKAEAESDALPDDT CCCHHHHCCCCCCCC | 34.92 | 29255136 | |
302 | Phosphorylation | SDALPDDTVIESEAL CCCCCCCCEEECCCC | 30.66 | 29255136 | |
306 | Phosphorylation | PDDTVIESEALPSDI CCCCEEECCCCCHHH | 19.62 | 29255136 | |
311 | Phosphorylation | IESEALPSDIAAEAR EECCCCCHHHHHHHH | 42.36 | 23927012 | |
320 | Ubiquitination | IAAEARAKTGGTVSD HHHHHHHHHCCCCCC | 41.99 | 21906983 | |
342 | Phosphorylation | DDAGEGPSSLIREKP CCCCCCCCCHHCCCC | 48.94 | 25627689 | |
343 | Phosphorylation | DAGEGPSSLIREKPV CCCCCCCCHHCCCCC | 30.83 | 25159151 | |
370 | Sumoylation | KEQTGNLKQELDDKS HHHHCCHHHHHCCCC | 45.81 | - | |
370 | Sumoylation | KEQTGNLKQELDDKS HHHHCCHHHHHCCCC | 45.81 | 28112733 | |
381 | Ubiquitination | DDKSATCKAYPKRPL CCCCCCCCCCCCCCC | 46.75 | 29967540 | |
394 | Phosphorylation | PLLGLVLTPTRELAV CCEEEEEECCHHHHH | 18.35 | 20068231 | |
396 | Phosphorylation | LGLVLTPTRELAVQV EEEEEECCHHHHHHH | 31.38 | 20068231 | |
404 | 2-Hydroxyisobutyrylation | RELAVQVKQHIDAVA HHHHHHHHHHHHHHH | 21.04 | - | |
404 | Ubiquitination | RELAVQVKQHIDAVA HHHHHHHHHHHHHHH | 21.04 | 33845483 | |
414 | Phosphorylation | IDAVARFTGIKTAIL HHHHHHHHCCCEEEE | 32.23 | 20860994 | |
425 | Sulfoxidation | TAILVGGMSTQKQQR EEEECCCCCHHHHHH | 3.01 | 21406390 | |
429 | Ubiquitination | VGGMSTQKQQRMLNR CCCCCHHHHHHHHCC | 48.78 | 22505724 | |
444 | Phosphorylation | RPEIVVATPGRLWEL CCCEEEECCCHHHHH | 18.05 | 28674419 | |
453 | Ubiquitination | GRLWELIKEKHYHLR CHHHHHHHHHCHHHC | 73.64 | 29967540 | |
455 | 2-Hydroxyisobutyrylation | LWELIKEKHYHLRNL HHHHHHHHCHHHCCH | 44.45 | - | |
475 | Methylation | LVVDEADRMVEKGHF EEEEHHHHHHHHCCH | 37.79 | - | |
503 | Phosphorylation | QYNPKRQTLVFSATL CCCCCCCCEEEEEEE | 28.99 | 20068231 | |
507 | Phosphorylation | KRQTLVFSATLTLVH CCCCEEEEEEEEHHH | 16.92 | 20068231 | |
509 | Phosphorylation | QTLVFSATLTLVHQA CCEEEEEEEEHHHHC | 21.05 | 20068231 | |
511 | Phosphorylation | LVFSATLTLVHQAPA EEEEEEEEHHHHCCH | 23.52 | 20068231 | |
532 | Phosphorylation | HTKKMDKTAKLDLLM HCCCCCHHHHHHHHH | 25.43 | 20068231 | |
534 | Acetylation | KKMDKTAKLDLLMQK CCCCHHHHHHHHHHH | 48.00 | 25953088 | |
541 | Acetylation | KLDLLMQKIGMRGKP HHHHHHHHHCCCCCC | 27.54 | 25953088 | |
541 | Ubiquitination | KLDLLMQKIGMRGKP HHHHHHHHHCCCCCC | 27.54 | - | |
547 | Ubiquitination | QKIGMRGKPKVIDLT HHHCCCCCCEEEECC | 31.16 | 24816145 | |
549 | Ubiquitination | IGMRGKPKVIDLTRN HCCCCCCEEEECCCC | 56.14 | 29967540 | |
567 | Ubiquitination | VETLTETKIHCETDE EEEEEECEEEEECCC | 24.99 | 29967540 | |
601 | Acetylation | ANSISCIKRLSGLLK HHHHHHHHHHHHHHH | 52.17 | 25953088 | |
601 | Ubiquitination | ANSISCIKRLSGLLK HHHHHHHHHHHHHHH | 52.17 | - | |
624 | Acetylation | LHACMHQKQRLRNLE HHHHHHHHHHHHCHH | 23.78 | 25953088 | |
624 | Sumoylation | LHACMHQKQRLRNLE HHHHHHHHHHHHCHH | 23.78 | 28112733 | |
624 | Ubiquitination | LHACMHQKQRLRNLE HHHHHHHHHHHHCHH | 23.78 | - | |
655 | Ubiquitination | ARGLDIPKVQHVIHY HCCCCCCCCEEEEEE | 55.66 | 33845483 | |
700 | Acetylation | PEDVINFKKIYKTLK HHHHCCHHHHHHHHC | 33.50 | 24431627 | |
700 | Ubiquitination | PEDVINFKKIYKTLK HHHHCCHHHHHHHHC | 33.50 | 21906983 | |
701 | Ubiquitination | EDVINFKKIYKTLKK HHHCCHHHHHHHHCC | 47.32 | 22817900 | |
703 | Phosphorylation | VINFKKIYKTLKKDE HCCHHHHHHHHCCCC | 13.55 | - | |
704 | Ubiquitination | INFKKIYKTLKKDED CCHHHHHHHHCCCCC | 51.35 | 22817900 | |
705 | Phosphorylation | NFKKIYKTLKKDEDI CHHHHHHHHCCCCCC | 27.17 | - | |
708 | Ubiquitination | KIYKTLKKDEDIPLF HHHHHHCCCCCCCCC | 70.26 | 29967540 | |
719 | Phosphorylation | IPLFPVQTKYMDVVK CCCCCCCCCHHHHHH | 25.11 | 29978859 | |
720 | 2-Hydroxyisobutyrylation | PLFPVQTKYMDVVKE CCCCCCCCHHHHHHH | 22.83 | - | |
720 | Ubiquitination | PLFPVQTKYMDVVKE CCCCCCCCHHHHHHH | 22.83 | 21906983 | |
726 | Ubiquitination | TKYMDVVKERIRLAR CCHHHHHHHHHHHHH | 40.92 | 23503661 | |
737 | Ubiquitination | RLARQIEKSEYRNFQ HHHHHHHHHHHHCHH | 50.66 | 24816145 | |
769 | Ubiquitination | ELEEDMYKGGKADQQ HCHHHHHCCCCHHHH | 55.33 | 22817900 | |
772 | Ubiquitination | EDMYKGGKADQQEER HHHHCCCCHHHHHHH | 58.41 | 22817900 | |
786 | Ubiquitination | RRRQKQMKVLKKELR HHHHHHHHHHHHHHH | 41.75 | 24816145 | |
797 | Phosphorylation | KELRHLLSQPLFTES HHHHHHHCCCCCCCC | 35.79 | 23312004 | |
804 | Phosphorylation | SQPLFTESQKTKYPT CCCCCCCCCCCCCCC | 33.64 | 28555341 | |
806 | Ubiquitination | PLFTESQKTKYPTQS CCCCCCCCCCCCCCC | 57.15 | 22817900 | |
807 | Phosphorylation | LFTESQKTKYPTQSG CCCCCCCCCCCCCCC | 28.33 | 28152594 | |
808 | Sumoylation | FTESQKTKYPTQSGK CCCCCCCCCCCCCCC | 57.16 | - | |
808 | Acetylation | FTESQKTKYPTQSGK CCCCCCCCCCCCCCC | 57.16 | 25953088 | |
808 | Sumoylation | FTESQKTKYPTQSGK CCCCCCCCCCCCCCC | 57.16 | 28112733 | |
808 | Ubiquitination | FTESQKTKYPTQSGK CCCCCCCCCCCCCCC | 57.16 | 22817900 | |
809 | Phosphorylation | TESQKTKYPTQSGKP CCCCCCCCCCCCCCC | 19.42 | 28152594 | |
811 | Phosphorylation | SQKTKYPTQSGKPPL CCCCCCCCCCCCCCE | 32.07 | 28152594 | |
813 | Phosphorylation | KTKYPTQSGKPPLLV CCCCCCCCCCCCEEE | 51.79 | 28152594 | |
815 | Acetylation | KYPTQSGKPPLLVSA CCCCCCCCCCEEEEC | 49.02 | 25953088 | |
815 | Ubiquitination | KYPTQSGKPPLLVSA CCCCCCCCCCEEEEC | 49.02 | 29967540 | |
821 | Phosphorylation | GKPPLLVSAPSKSES CCCCEEEECCCCCHH | 34.14 | 27251275 | |
824 | Phosphorylation | PLLVSAPSKSESALS CEEEECCCCCHHHHH | 48.83 | 28555341 | |
825 | Acetylation | LLVSAPSKSESALSC EEEECCCCCHHHHHH | 58.12 | 26051181 | |
825 | Sumoylation | LLVSAPSKSESALSC EEEECCCCCHHHHHH | 58.12 | 28112733 | |
826 | Phosphorylation | LVSAPSKSESALSCL EEECCCCCHHHHHHH | 40.91 | 20068231 | |
828 | Phosphorylation | SAPSKSESALSCLSK ECCCCCHHHHHHHHH | 41.42 | 20068231 | |
831 | Phosphorylation | SKSESALSCLSKQKK CCCHHHHHHHHHHHC | 16.84 | 20068231 | |
834 | Phosphorylation | ESALSCLSKQKKKKT HHHHHHHHHHHCCCC | 37.05 | 25159151 | |
835 | Acetylation | SALSCLSKQKKKKTK HHHHHHHHHHCCCCC | 53.87 | 25953088 | |
835 | Ubiquitination | SALSCLSKQKKKKTK HHHHHHHHHHCCCCC | 53.87 | 33845483 | |
857 | Phosphorylation | EQPQPSTSAN----- CCCCCCCCCC----- | 30.10 | 25627689 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DDX24_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DDX24_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17 AND LYS-71, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-94; SER-287 ANDSER-295, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-94; SER-287;SER-295 AND THR-302, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND SER-192, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND THR-302, AND MASSSPECTROMETRY. |